| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |